<?xml version="1.0" encoding="UTF-8"?>
<p id="para0006">Many drugs have been hypothesized to be directly active against COVID-19 only because of a supposed antiviral activity: remdesivir, a molecule originally tested against Ebola virus, shows in vivo activity against MERS-CoV
 <xref rid="bib0005" ref-type="bibr">
  <sup>5</sup>
 </xref> but there is actually no real evidence of in vivo activity against COVID-19; lopinavir/ritonavir, a well-known protease inhibitor used in HIV treatment, has been widely used before randomized clinical trials showed his inefficacy in mortality reduction
 <xref rid="bib0006" ref-type="bibr">
  <sup>6</sup>
 </xref>; chloroquine and hydroxychloroquine, which are largely used in systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) treatment, show modest antiviral effects, but mortality due to QT elongation-related cardiac events is a matter of concern.
 <xref rid="bib0007" ref-type="bibr">
  <sup>7</sup>
 </xref>
</p>
